Enter your search terms:
Top

Uncategorized

MonoSol Rx, LLC Asserts Additional Patents to Infringement Lawsuit Against BioDelivery Sciences International, Inc.

Newly Asserted Patents Pre-Date Milestone and Revenue Payments Warren, NJ (October 26, 2011) – MonoSol Rx, LLC (“MonoSol Rx”), the developer of PharmFilm® drug delivery technology, today announced that it has filed a second amended complaint in its litigation against BioDelivery Sciences International, Inc. (NASDAQ: BDSI; “BDSI”),...

MonoSol Rx Aligns Executive Leadership to Maximize Growth Opportunities, Operational Excellence and R&D Pipeline

Mark Schobel, CEO, Assumes Added Role of Chief Technology Officer; Keith Kendall, CFO, Named Chief Operating Officer Schobel and Kendall to Serve as Co-Presidents Warren, NJ (June 23, 2011) – MonoSol Rx, the developers of PharmFilm® technology and a drug delivery company specializing in proprietary pharmaceutical film products, announced today...

MonoSol Rx Announces Reckitt Benckiser FDA Approval of Suboxone Sublingual Film for Treatment of Opioid Dependence

Second FDA-Approval Drug Based on MonoSol Rx's PharmFilm® Technology; First Sublingually-Administered Prescription Film Product Warren, NJ (August 31, 2010) – MonoSol Rx, the developers of PharmFilm® technology and a drug delivery company specializing in film pharmaceutical products, today announced that its partner, Reckitt Benckiser Pharmaceuticals Inc., a wholly-owned subsidiary of...